{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:27:35Z","timestamp":1790634455232,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.gofs.2018.10.008","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T21:46:20Z","timestamp":1541886380000},"page":"865-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["La contraception apr\u00e8s 40\u00a0ans. RPC Contraception CNGOF"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Begon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hock\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2018.10.008_bib0840","first-page":"012","article-title":"Contraception\u00a0: recommandations pour la pratique clinique du CNGOF (texte court)","volume":"46","author":"Chabbert-Buffet","year":"2018","journal-title":"Fynecol Obstet Fertil Senol"},{"key":"10.1016\/j.gofs.2018.10.008_bib0425","article-title":"P\u00e9rim\u00e9nopause","author":"Dumont","year":"2016","journal-title":"EMC \u2013 Gyn\u00e9cologie"},{"key":"10.1016\/j.gofs.2018.10.008_bib0845","first-page":"005","article-title":"RPC Contraception CNGOF","volume":"46","author":"Contexte de la contraception en France","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.gofs.2018.10.008_bib0430","series-title":"Barom\u00e8tre sant\u00e9 2016. Contraception. Quatre ans apr\u00e8s la crise de la pilule les \u00e9volutions se poursuivent","author":"Rahib","year":"2017"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.008_bib0435","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/humrep\/deh304","article-title":"Can assisted reproduction technology compensate for the natural decline in fertility with age\u00a0? A model assessment","volume":"19","author":"Leridon","year":"2004","journal-title":"Hum Reprod Oxf Engl"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0440","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3917\/popu.1403.0365","article-title":"Le nombre d\u2019IVG est stable, mais moins de femmes y ont recours","volume":"69","author":"Mazuy","year":"2014","journal-title":"Population"},{"key":"10.1016\/j.gofs.2018.10.008_bib0445","series-title":"Statistical bulletin: Conceptions in England and Wales: 2016","author":"Haines","year":"2018"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.008_bib0450","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/1471-0528.12694","article-title":"Risk factors for miscarriage from a prevention perspective: a nationwide follow-up study","volume":"121","author":"Feodor Nilsson","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0455","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/EDE.0000000000000818","article-title":"Absolute risks of obstetric outcomes risks by maternal age at first birth: a population-based cohort","volume":"29","author":"Schummers","year":"2018","journal-title":"Epidemiol Camb Mass"},{"key":"10.1016\/j.gofs.2018.10.008_bib0460","series-title":"La sant\u00e9 des femmes en France\u00a0; dossier sexualit\u00e9, contraception pr\u00e9vention et rapports de genre","author":"Bajos","year":"2010"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.008_bib0465","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/jsm.12267","article-title":"Women's sexuality: from aging to social representations","volume":"10","author":"Ringa","year":"2013","journal-title":"J Sex Med"},{"issue":"9907","key":"10.1016\/j.gofs.2018.10.008_bib0470","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(13)62035-8","article-title":"Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)","volume":"382","author":"Mercer","year":"2013","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0475","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0956462416684402","article-title":"Sexual health of women aged 40\u00a0and over attending an inner city integrated sexual health clinic","volume":"28","author":"Grech","year":"2017","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.gofs.2018.10.008_bib0480","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011054.pub2","article-title":"Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Fertility Regulation Group, \u00e9diteur","author":"Roach","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"24","key":"10.1016\/j.gofs.2018.10.008_bib0485","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.008_bib0490","first-page":"170","article-title":"L\u2019hypertension art\u00e9rielle en France\u00a0: pr\u00e9valence, traitement et contr\u00f4le en 2015\u00a0et \u00e9volutions depuis 2006","author":"Perrine","year":"2018","journal-title":"Bull Epid\u00e9miol Hebd"},{"issue":"16","key":"10.1016\/j.gofs.2018.10.008_bib0495","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.jacc.2018.02.033","article-title":"Hypertension Across a Woman's Life Cycle","volume":"71","author":"Wenger","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.gofs.2018.10.008_bib0500","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0505","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40264-014-0149-8","article-title":"Thromboembolic Events in Women Exposed to Hormonal Contraception or Cyproterone Acetate in 2012: A Cross-Sectional Observational Study in 30\u00a0French Public Hospitals","volume":"37","author":"Gourbil","year":"2014","journal-title":"Drug Saf"},{"issue":"16","key":"10.1016\/j.gofs.2018.10.008_bib0510","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0515","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0520","first-page":"e21","article-title":"Heart disease and stroke statistics \u2013 2009\u00a0update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0525","doi-asserted-by":"crossref","first-page":"E868","DOI":"10.1210\/jc.2011-3357","article-title":"Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women","volume":"97","author":"Polotsky","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0530","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/GRF.0b013e318208010e","article-title":"Benign breast diseases: epidemiology, evaluation, and management","volume":"54","author":"Rungruang","year":"2011","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0535","first-page":"41","article-title":"Non-Contraceptive Benefits of Oral Hormonal Contraceptives","volume":"11","author":"Schindler","year":"2013","journal-title":"Int J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0540","first-page":"283","article-title":"Risk factors for benign breast disease: a 30-year cohort study","volume":"124","author":"Hislop","year":"1981","journal-title":"Can Med Assoc J"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0545","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2007.08.011","article-title":"Oral contraceptives and benign breast disease: an update of findings in a large cohort study","volume":"76","author":"Vessey","year":"2007","journal-title":"Contraception"},{"issue":"6C","key":"10.1016\/j.gofs.2018.10.008_bib0550","first-page":"3997","article-title":"Incidence of benign and malignant breast disorders in women taking hormones (contraceptive pill or hormonal replacement therapy)","volume":"16","author":"Tzingounis","year":"1996","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0555","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a113089","article-title":"Risk factors for benign breast disease","volume":"113","author":"Brinton","year":"1981","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0560","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/oxfordjournals.epirev.a017960","article-title":"Epidemiology of benign breast disease, with special attention to histologic types","volume":"19","author":"Goehring","year":"1997","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.gofs.2018.10.008_bib0565","first-page":"3","article-title":"Contraception et mastopathies b\u00e9nignes","volume":"357","author":"Hamy","year":"2010","journal-title":"Lett Gyn\u00e9cologue"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0570","first-page":"424","article-title":"Epidemiology of uterine myomas: a review","volume":"9","author":"Sparic","year":"2016","journal-title":"Int J Fertil Steril"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0575","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0015-0282(98)00208-8","article-title":"A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata","volume":"70","author":"Marshall","year":"1998","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0580","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"9","key":"10.1016\/j.gofs.2018.10.008_bib0585","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1055\/s-0033-1350840","article-title":"Adenomyosis: Epidemiology, Risk Factors, Clinical Phenotype and Surgical and Interventional Alternatives to Hysterectomy","volume":"73","author":"Taran","year":"2013","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0590","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.rbmo.2014.11.005","article-title":"Adenomyosis: a life-cycle approach","volume":"30","author":"Benagiano","year":"2015","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0595","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jgyn.2006.12.011","article-title":"Ad\u00e9nomyose","volume":"36","author":"Fernandez","year":"2007","journal-title":"J Gyn\u00e9cologie Obst\u00e9trique Biol Reprod"},{"key":"10.1016\/j.gofs.2018.10.008_bib0910","article-title":"Contraception et cancer RPC Contraception CNGOF","volume":"46","author":"Pragout","year":"2018","journal-title":"Gynecol ObstetFertil Senol"},{"key":"10.1016\/j.gofs.2018.10.008_bib0600","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.gofs.2018.10.008_bib0605","series-title":"FSRH Guideline. Contraception for Women Aged Over 40\u00a0Years","author":"Faculty of Sexual Reproductive Healthcare","year":"2017"},{"key":"10.1016\/j.gofs.2018.10.008_bib0610","series-title":"Contraception: prescriptions et conseils aux femmes","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2013"},{"issue":"10","key":"10.1016\/j.gofs.2018.10.008_bib0615","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1701-2163(16)30033-0","article-title":"Canadian Contraception Consensus (Part 1\u00a0of 4)","volume":"37","author":"Black","year":"2015","journal-title":"J Obstet Gynaecol Can JOGC"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0620","first-page":"1","article-title":"U.S. Selected Practice Recommendations for Contraceptive Use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"10.1016\/j.gofs.2018.10.008_bib0855","article-title":"Contraception hormonale et risque vasculaire. RPC Contraception CNGOF","volume":"46","author":"Plu-Bureau","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0625","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.thromres.2012.05.024","article-title":"Risk factors for venous thromboembolism in pre-and postmenopausal women","volume":"130","author":"Bergendal","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.gofs.2018.10.008_bib0630","series-title":"Pr\u00e9vention et d\u00e9pistage du diab\u00e8te de type 2\u00a0et des maladies li\u00e9es au diab\u00e8te","author":"Haute Autorit\u00e9 de Sant\u00e9","year":"2014"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0635","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.maturitas.2005.10.007","article-title":"Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density","volume":"54","author":"Gambacciani","year":"2006","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0640","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11154-011-9180-6","article-title":"Update on hormonal contraception and bone density","volume":"12","author":"Isley","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0645","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00042192-200107000-00011","article-title":"A scheme of combined oral contraceptives for women more than 40\u00a0years old","volume":"8","author":"Bl\u00fcmel","year":"2001","journal-title":"Menopause N Y N"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.008_bib0650","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/ije\/dyw147","article-title":"Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence","volume":"45","author":"Wang","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0655","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1210\/jc.2010-2065","article-title":"Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis","volume":"96","author":"Chakhtoura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0660","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/STROKEAHA.108.538405","article-title":"Progestogen-only contraceptives and the risk of stroke: a meta-analysis","volume":"40","author":"Chakhtoura","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.gofs.2018.10.008_bib0665","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0670","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/13625187.2015.1079610","article-title":"Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception","volume":"21","author":"Napolitano","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0675","first-page":"57","article-title":"Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers","volume":"35","author":"K\u00fc\u00e7\u00fck","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0680","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.beem.2012.11.002","article-title":"Hormonal contraceptives and venous thromboembolism: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0685","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: A systematic review","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.008_bib0690","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","volume":"57","year":"1998","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0695","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0010-7824(91)90032-B","article-title":"Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile","volume":"44","author":"Fahmy","year":"1991","journal-title":"Contraception"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib0700","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(00)00168-2","article-title":"Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study","volume":"62","author":"Tang","year":"2000","journal-title":"Contraception"},{"issue":"7","key":"10.1016\/j.gofs.2018.10.008_bib0705","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1471-0528.1998.tb10211.x","article-title":"Bone density in long term users of depot medroxyprogesterone acetate","volume":"105","author":"Gbolade","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.008_bib0710","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2265.1998.00582.x","article-title":"The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women","volume":"49","author":"Orr-Walker","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0715","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-016-3714-4","article-title":"The impact of depot medroxyprogesterone acetate on fracture risk: a case-control study from the UK","volume":"28","author":"Kyvernitakis","year":"2017","journal-title":"Osteoporos Int J Establ Result Coop"},{"key":"10.1016\/j.gofs.2018.10.008_bib0720","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","volume":"7","author":"Lopez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0725","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","article-title":"The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women","volume":"78","author":"Vestergaard","year":"2008","journal-title":"Contraception"},{"issue":"11","key":"10.1016\/j.gofs.2018.10.008_bib0730","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1210\/jc.2010-0032","article-title":"Use of Depot Medroxyprogesterone Acetate and Fracture Risk","volume":"95","author":"Meier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0735","doi-asserted-by":"crossref","first-page":"57.e1","DOI":"10.1016\/j.ajog.2017.03.005","article-title":"Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study","volume":"217","author":"Phillips","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.077","article-title":"Long-term utilization and continuation of intrauterine devices","volume":"213","author":"Diedrich","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0745","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.contraception.2014.02.011","article-title":"Extended use of the intrauterine device: a literature review and recommendations for clinical practice","volume":"89","author":"Wu","year":"2014","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.008_bib0750","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.contraception.2004.12.026","article-title":"TCu 380A IUD: a reversible permanent contraceptive method in women over 35\u00a0years of age","volume":"72","author":"Bahamondes","year":"2005","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0755","first-page":"341","article-title":"Long-term reversible contraception: Twelve years of experience with the TCu380A and TCu220C","volume":"56","author":"World Health Organization","year":"1997","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0760","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/humupd\/dmp020","article-title":"Female contraception over 40","volume":"15","author":"The ESHRE Capri Workshop Group","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.gofs.2018.10.008_bib0860","article-title":"Contraception intra-ut\u00e9rine. RPC Contraception CNGOF","volume":"46","author":"Vidal","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0765","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0010-7824(02)00329-3","article-title":"Acceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: results of a French clinical study in women aged 35\u00a0to 45\u00a0years","volume":"66","author":"Dubuisson","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.gofs.2018.10.008_bib0770","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002126.pub3","article-title":"Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Gynaecology and Fertility Group, \u00e9diteur","author":"Lethaby","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0775","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1272\/jnms.79.190","article-title":"Changes in bone mineral density of users of the levonorgestrel-releasing intrauterine system","volume":"79","author":"Yang","year":"2012","journal-title":"J Nippon Med Sch Nippon Ika Daigaku Zasshi"},{"issue":"5","key":"10.1016\/j.gofs.2018.10.008_bib0780","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/humrep\/deq043","article-title":"Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system","volume":"25","author":"Bahamondes","year":"2010","journal-title":"Hum Reprod Oxf Engl"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0785","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.11.009","article-title":"Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer","volume":"83","author":"Dinger","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0790","doi-asserted-by":"crossref","first-page":"586e1","DOI":"10.1016\/j.ajog.2017.01.036","article-title":"Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2\u00a0years beyond Food and Drug Administration-approved duration","volume":"216","author":"McNicholas","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.gofs.2018.10.008_bib0795","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2009.01.004","article-title":"Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system","volume":"80","author":"Hidalgo","year":"2009","journal-title":"Contraception"},{"issue":"8","key":"10.1016\/j.gofs.2018.10.008_bib0800","first-page":"716","article-title":"Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12\u00a0years of continuous use","volume":"78","author":"R\u00f6nnerdag","year":"1999","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0805","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.contraception.2017.10.007","article-title":"Pregnancy outcomes associated with extended use of the 52-mg 20\u03bcg\/day levonorgestrel-releasing intrauterine system beyond 60\u00a0months: a chart review of 776\u00a0women in Brazil","volume":"97","author":"Bahamondes","year":"2018","journal-title":"Contraception"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0810","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/09513590.2013.774364","article-title":"Potential health benefits of continuous LNG-IUS combined with parenteral ERT for seamless menopausal transition and beyond\u2013a commentary based on clinical experience","volume":"29","author":"Wildemeersch","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"12","key":"10.1016\/j.gofs.2018.10.008_bib0815","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/GME.0000000000000557","article-title":"Use of a levonorgestrel-containing intrauterine system with supplemental estrogen improves symptoms in perimenopausal women: a pilot study","volume":"22","author":"Santoro","year":"2015","journal-title":"Menopause N Y N"},{"key":"10.1016\/j.gofs.2018.10.008_bib0865","article-title":"M\u00e9thodes de contraception naturelle et m\u00e9thodes barri\u00e8res. RPC Contraception CNGOF","volume":"46","author":"Hassoun","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"Suppl 1","key":"10.1016\/j.gofs.2018.10.008_bib0820","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S1166-7087(12)70029-5","article-title":"Influence of aging on male sexual health","volume":"22","author":"Seisen","year":"2012","journal-title":"Progres En Urol J Assoc Francaise"},{"key":"10.1016\/j.gofs.2018.10.008_bib0870","article-title":"La contraception d\u2019urgence. RPC Contraception CNGOF","volume":"46","author":"Hamdaoui","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"6","key":"10.1016\/j.gofs.2018.10.008_bib0825","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.bpobgyn.2014.05.006","article-title":"The contraception needs of the perimenopausal woman","volume":"28","author":"Hardman","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.gofs.2018.10.008_bib0830","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5122(92)90003-M","article-title":"The normal menopause transition","volume":"14","author":"McKinlay","year":"1992","journal-title":"Maturitas"},{"issue":"3","key":"10.1016\/j.gofs.2018.10.008_bib0835","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.maturitas.2013.07.009","article-title":"Contraception during the perimenopause","volume":"76","author":"Baldwin","year":"2013","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.gofs.2018.10.008_bib1450","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2007.06.005","article-title":"Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40\u00a0years of age","volume":"76","author":"Juliato","year":"2007","journal-title":"Contraception"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918302630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:23:11Z","timestamp":1551208991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918302630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":91,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2468718918302630"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.008","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La contraception apr\u00e8s 40\u00a0ans. RPC Contraception CNGOF","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}